Prevision Medicine raises funding

Prevision Medicine develops drug screening technologies to personalise cancer treatment. The company has joined the Biopôle Investment Programme, which offers non-dilutive funding of up to CHF 90,000.

Announced on
Round
Grant
Amount
Amount not disclosed
Location
canton of Zurich
Sector
Health & medtech

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic